KITE PHARMA
Investor
KITE PHARMA
Description
Kite Pharma develops an engineered T cell therapy designed for hematologic malignancies.
KITE PHARMA
Address
United States
Contact
Description
Kite Pharma develops an engineered T cell therapy designed for hematologic malignancies.
Matchmaking
Connect with KITE PHARMA
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways